FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Börse Stuttgart 15:52:50 2024-05-31 EDT | ||
| 8.38 EUR | -5.10% |
|
| Current month | -6.68% | ||
| 1 month | -6.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 8.38 | -5.10% |
| 24-05-30 | 8.83 | +0.11% |
| 24-05-29 | 8.82 | +1.38% |
| 24-05-28 | 8.7 | +5.58% |
| 24-05-27 | 8.24 | -1.08% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 03:52 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG3D86 |
| ISIN | DE000MG3D866 |
| Date issued | 2024-04-30 |
| Strike | 185.8 $ |
| Maturity | Unlimited |
| Parity | 4.95 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.58 € |
|---|---|
| Lowest since issue | 7.66 € |
| Spread | 0.04 € |
| Spread % | 0.48% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
142
USD
Average target price
147
USD
Spread / Average Target
+3.54%
- Stock Market
- Certificates
- Certificat
